BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 33282948)

  • 1. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
    Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
    Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
    Lei X; Zhang M; Guan B; Chen Q; Dong Z; Wang C
    Hum Genomics; 2021 Jun; 15(1):39. PubMed ID: 34187556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes That Predict Poor Prognosis in Breast Cancer via Bioinformatical Analysis.
    Zhou Q; Liu X; Lv M; Sun E; Lu X; Lu C
    Biomed Res Int; 2021; 2021():6649660. PubMed ID: 33959662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
    Wei J; Wang Y; Shi K; Wang Y
    Biomed Res Int; 2020; 2020():8959210. PubMed ID: 32258155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer.
    Yang Y; Sheng Y; Zheng J; Ma A; Chen S; Lin J; Yang X; Liang Y; Zhang Y; Zheng X
    Biomarkers; 2024 Jun; 29(4):185-193. PubMed ID: 38568742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CENPE, PRC1, TTK, and PLK4 May Play Crucial Roles in the Osteosarcoma Progression.
    Wang F; Zhao Q; Liu W; Kong D
    Technol Cancer Res Treat; 2020; 19():1533033820973278. PubMed ID: 33176597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
    Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
    J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.